Clinical Scorecard: Lack of SARS-CoV-2 Detection in Placental Tissue Following Maternal COVID-19 Infection
At a Glance
Category
Detail
Condition
Key Mechanisms
Absence of SARS-CoV-2 protein and RNA in placental tissue post-recovery; potential immune-mediated pathology suggested.
Target Population
Care Setting
Key Highlights
No detectable SARS-CoV-2 protein or RNA in placental tissue months after maternal infection, indicating low likelihood of ongoing infection.
Acute COVID-19 placentitis associated with stillbirth and placental injury, but post-recovery placental health appears unaffected by viral persistence.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Focus on managing placental health and monitoring for complications rather than treating for viral infection.
A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.
